4D Molecular Therapeutics
FDMT
FDMT
143 hedge funds and large institutions have $1.2B invested in 4D Molecular Therapeutics in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 32 closing their positions.
Holders
143
Holders Change
-4
Holders Change %
-2.72%
% of All Funds
2.08%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.01%
New
29
Increased
54
Reduced
37
Closed
32
Calls
$1.19M
Puts
$4.54M
Net Calls
-$3.35M
Net Calls Change
-$14.9M
Top Buyers
1 |
1
Goldman Sachs
New York
|
$86.8M |
2 |
DTC
2
Deep Track Capital
Greenwich,
Connecticut
|
$85.2M |
3 |
3
BlackRock
New York
|
$103M |
4 |
PAM
4
Panagora Asset Management
Boston,
Massachusetts
|
$7.45M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$22.3M |